KINGDON CAPITAL MANAGEMENT, L.L.C. - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.

Quarter-by-quarter ownership
KINGDON CAPITAL MANAGEMENT, L.L.C. ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q1 2022$39,876,000
-42.2%
336,306
-32.8%
4.16%
-47.6%
Q4 2021$68,956,000
+35.9%
500,373
+36.9%
7.93%
+28.4%
Q3 2021$50,754,000
+30.4%
365,373
-8.9%
6.18%
+36.9%
Q2 2021$38,930,000
-33.8%
401,006
-53.4%
4.51%
-24.9%
Q1 2021$58,799,000
-50.3%
860,261
-37.7%
6.01%
-53.1%
Q4 2020$118,303,000
+38.9%
1,380,261
+5.3%
12.80%
+33.8%
Q3 2020$85,180,000
-16.9%
1,310,261
-6.6%
9.56%
+2.5%
Q2 2020$102,519,000
+106.0%
1,402,261
-4.1%
9.33%
+2.3%
Q1 2020$49,778,000
-27.3%
1,462,761
+16.3%
9.11%
-11.7%
Q4 2019$68,486,000
+30.6%
1,258,020
+0.1%
10.32%
+66.5%
Q3 2019$52,433,000
+19.6%
1,256,774
+25.5%
6.19%
+43.7%
Q2 2019$43,852,000
-9.8%
1,001,410
+6.1%
4.31%
-33.6%
Q1 2019$48,601,000
+95.9%
944,266
+40.8%
6.50%
+73.7%
Q4 2018$24,804,000
+6.1%
670,738
+7.8%
3.74%
+129.5%
Q3 2018$23,368,000
-1.1%
622,328
+4.1%
1.63%
-1.1%
Q2 2018$23,617,000
+77.8%
597,596
+15.9%
1.65%
+57.0%
Q1 2018$13,285,000515,7371.05%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2020
NameSharesValueWeighting ↓
RP Management, LLC 1,111,111$107,867,00052.60%
Knoll Capital Management, LLC 856,844$83,182,00043.44%
ORACLE INVESTMENT MANAGEMENT INC 2,082,555$202,174,00027.86%
ARS Investment Partners, LLC 558,286$54,198,0005.52%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$17,113,0004.52%
KINGDON CAPITAL MANAGEMENT, L.L.C. 401,006$38,930,0004.51%
Eventide Asset Management 1,990,797$193,267,0002.60%
SILVERARC CAPITAL MANAGEMENT, LLC 56,626$5,497,0002.45%
Avidity Partners Management LP 882,500$85,673,0002.32%
Nicholas Investment Partners, LP 363,708$35,309,0002.22%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders